These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23133847)

  • 1. [Risks in atrial fibrillation and simultaneous renal failure].
    Habich S
    Dtsch Med Wochenschr; 2012 Sep; 137(38):1840. PubMed ID: 23133847
    [No Abstract]   [Full Text] [Related]  

  • 2. Stroke and bleeding in atrial fibrillation with chronic kidney disease.
    Olesen JB; Lip GY; Kamper AL; Hommel K; Køber L; Lane DA; Lindhardsen J; Gislason GH; Torp-Pedersen C
    N Engl J Med; 2012 Aug; 367(7):625-35. PubMed ID: 22894575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Triple therapy" or triple threat? Balancing the risks of antithrombotic therapy for patients with atrial fibrillation and coronary stents.
    Francescone S; Halperin JL
    J Am Coll Cardiol; 2008 Feb; 51(8):826-7. PubMed ID: 18294567
    [No Abstract]   [Full Text] [Related]  

  • 4. [Guidelines for antithrombotic therapy in atrial fibrillation: what the Italian Hemostasis and Thrombosis Society thinks].
    Prisco D
    Haematologica; 2001 Sep; 86(9 Suppl):12-3. PubMed ID: 11759618
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 6. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
    Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antithrombotic treatment in chronic nonrheumatic atrial fibrillation].
    Koskinen P; Kupari M; Halinen MO
    Duodecim; 1993; 109(19):1631-7. PubMed ID: 7736980
    [No Abstract]   [Full Text] [Related]  

  • 8. What is the most effective and safest delivery of thromboprophylaxis in atrial fibrillation?
    Lip GY
    J R Coll Physicians Edinb; 2012; 42 Suppl 18():35-44. PubMed ID: 22518392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboprophylaxis in atrial fibrillation: why, how, when and how can we do better?
    Watson T; Lip GY
    Int J Clin Pract; 2006 Mar; 60(3):252-5. PubMed ID: 16494636
    [No Abstract]   [Full Text] [Related]  

  • 10. Post-stenting antithrombotic drug therapy in patients with atrial fibrillation.
    Lip GY
    Am J Med; 2007 Nov; 120(11):920-2. PubMed ID: 17976413
    [No Abstract]   [Full Text] [Related]  

  • 11. Aspirin for atrial fibrillation.
    Douglas M; Strelnick A
    J Fam Pract; 2000 Jan; 49(1):7-8. PubMed ID: 10678329
    [No Abstract]   [Full Text] [Related]  

  • 12. Balancing risk in atrial fibrillation.
    Ali SN; Hardman SM
    Practitioner; 2001 May; 245(1622):357. PubMed ID: 11373966
    [No Abstract]   [Full Text] [Related]  

  • 13. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S; Trappolini M; Chillotti FM
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based emergency medicine. Anticoagulation or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.
    Diner BM
    Ann Emerg Med; 2003 Jan; 41(1):141-3. PubMed ID: 12514695
    [No Abstract]   [Full Text] [Related]  

  • 15. [Atrial fibrillation--thromboembolism and prevention].
    Petersen P; Boysen G; Godtfredsen J
    Ugeskr Laeger; 1991 Jul; 153(30):2105-7. PubMed ID: 1866811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thromboembolic complications in the course of non-valvular atrial fibrillation].
    Mas JL
    Rev Prat; 1995 Apr; 45(8):935-41. PubMed ID: 7761775
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factors for thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.
    Petersen P; Kastrup J; Helweg-Larsen S; Boysen G; Godtfredsen J
    Arch Intern Med; 1990 Apr; 150(4):819-21. PubMed ID: 2183733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of thromboembolism in non-valvular atrial fibrillation].
    Coccheri S; Cosmi B
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):927-9. PubMed ID: 12497850
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
    Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thromboembolism in non-rheumatic atrial fibrillation].
    Pengo V
    Haematologica; 2001 Sep; 86(9 Suppl):5-11. PubMed ID: 11759619
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.